Even with acquiring a whole reaction with optimal induction therapy, minimal residual disease usually persists, necessitating consolidation therapy to mitigate the risk of relapse by getting rid of residual disease. In individuals which have gained seven+3 induction therapy, consolidation therapy is initiated with superior-dose cytarabine, often k